Video » Interview Updated Cumulative Results of Treatment with Mavacamten from the EXPLORER-LTE Cohort of the MAVA-LTE Study in Patients with Obstructive Hypertrophic Cardiomyopathy May 4, 2022
Video » Interview The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis May 4, 2022
Video » Interview SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure May 4, 2022
Video » Interview METEORIC-HF: The Effect of Omecamtiv Mecarbil on Exercise Tolerance In Patients with Chronic Heart Failure and Reduced Ejection Fraction May 4, 2022
Video » Interview GIPS-IV: The Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate After St-segment Elevation Myocardial Infarction May 4, 2022
Video » Interview EDIT-CMD Randomized Clinical Trial: Efficacy Of Diltiazem To Improve Coronary Vasomotor Dysfunction In Angina And Nonobstructive Coronary Arteries May 4, 2022
Video » Interview APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial May 4, 2022
Video » Interview A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement May 4, 2022
Video » Interview "Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Results of the VALOR Trial" May 4, 2022
Video » Interview ACC 2022: PACMAN AMI - Effects Of Alirocumab On Coronary Atherosclerosis Assessed By Serial Multimodality Intracoronary Imaging In Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial April 12, 2022
Video » Interview ACC 2022: The POISE-3 Trial: Efficacy and Safety of Tranexamic Acid in Patients Undergoing Noncardiac Surgery April 12, 2022
Video » Interview ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib April 3, 2022